Physician profile
Radit Aur
NPI 1255748596
$4,492.79
in general payments reported to CMS, 2019-2025
20 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $862 · 2022: $689 · 2023: $652 · 2024: $1,030 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $804.18 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $593.60 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $517.84 | 2021-2024 | Xifaxan |
| Amgen INC. | $512.15 | 2023-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $430.37 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Pfizer INC. | $384.75 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.80 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $215.37 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $191.73 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $108.95 | 2023-2025 | |
| Exact Sciences Corporation | $73.39 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $71.43 | 2022-2024 | Farxiga |
| Boston Scientific Corporation | $57.59 | 2025 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $55.36 | 2022-2023 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $48.91 | 2024 | Voquezna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $37.85 | 2023 | Talicia |
| Echosens North America, INC. | $27.32 | 2025 | Fibroscan |
| Hologic Sales and Service, LLC | $23.57 | 2025 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $20.34 | 2024 | Slynd |
| Cranial Technologies, INC | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radit Aur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.